Search

Issue
Title
Authors
Current trends in drug therapy for resectable locally advanced gastric cancer
Titov K.S., Andreytsev I.L., Grekov D.N., Kuzmenko A.A., Lebedev S.S., Podzolkova N.M., Chekini A.K., Sokolov N.Y., Minenkova A.G.
Prevalence of chronic kidney disease among cancer patients
Трофимцева Т.Н., Yarovoy S.K., Gritskevich A.A.
VPERVYE VYYaVLENNYY GINEKOLOGIChESKIY RAK KAK PRIChINA SMERTI V MNOGOPROFIL'NOM STATsIONARE
Vertkin A.K., Kozhushkov A.I., Kozlova O.V.
Evaluation of the efficacy of pembrolizumab in patients with metastatic cervical cancer depending on the value of the neutrophil-lymphocyte index
Orlova R.V., Gorkina Y.R.
Prognostic value of low HER2 expression in patients with early breast cancer
Bekkeldiyeva N.B., Semiglazov V.F., Kudaibergenova A.G., Emelyanov A.S., Nikolaev K.S., Mortada V.V., Zernov K.Y., Raimzhanov C.A., Tabagua T.T., Pesotsky R.S., Bondarchuk Y.I., Amirov N.S., Enaldieva D.A., Ulrikh D.G., Levchenko V.E., Krivorotko P.V.
Vaginal microbiome and HPV persistence: the role of bacterial vaginosis in cervical carcinogenesis
Iurova M.V., Abakarova P.R., Mezhevitinova E.A., Aksenova A.V.
TIME COURSE AND PROGNOSIS OF BENIGN AND MALIGNANT TUMORS OF THE FEMALE REPRODUCTIVE SYSTEM ON THE BACKGROUND OF COMORBID CONDITIONS
Vertkin A.L., Kozlova O.V., Khashukoeva A.Z., Vertkin A., pl?midmagidsid h.h., Khashukoyeva A.Z.
Osobennosti klinicheskogo techeniya invazivnogo dol'kovogo raka molochnoy zhelezy
Borisova E.I., Vyshinskaya G.V., Gutorov S.L., Stepanchenko M.V.
Cardiac toxicity of fluoropyrimidines in the treatment of solid gastrointestinal tumors
Bogatyreva L.R., Besova N.S., Yunayev G.S., Kurmukov I.A., Obarevich E.S., Gavrilova D.A., Egorova A.V., Lepkova N.V., Tryakin A.A.
Clinical significance of morphological ultrastaging in breast and uterine cancer
Khakimova G.G., Reshetov I.V., Zikiryakhodjaev A.D., Khakimova S.G.
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
Gritskevich A.A., Byteman T.P., Monakov D.M., Rusakov I.G., Mishugin S.V.
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S.V., Laytsan K.Y., Stroyakovskiy D.L., Demidova I.A., Gorbunova V.A.
Avastin (bevacizumab) in the treatment of tumors of the stomach and pancreas
Semenov N.N.
Nasopharyngeal cancer. ESMO 2024 news
Golubev P.V., Bolotina L.V., Kuzmina E.S., Pokataev I.A., Golubeva A.V., Kyanzhin E.P., Kuzmin V.M., Galkin V.N.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K.S., Vorontsova K.A., Kuko T.M., Prosvirnov A.A., Ganshina I.P., Lubennikova E.V., Kolyadina I.V., Zhukova L.G.
POTENTIALS FOR THE EARLY DIAGNOSIS AND PREVENTION OF SKIN CANCER
Sergeev Y.Y., Olisova O.Y., Sergeev V.Y.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S.L., Stepanchenko M.V., Lichinitser M.R.
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.B.
Modern approaches to the treatment of muscle-invasive bladder cancer
He Mingze -., Zeng Zitong -.
CAPECITABINE AND FLUOROURACIL IN THE TREATMENT OF COLORECTAL CANCER AND GASTRIC CANCER: ANALYSIS OF DIRECT COMPARATIVE STUDIES
Fedyanin M.Y., Tryakin A.A., Fedyanin M.Y., Tryakin A.A.
Algorithm for diagnostics and systemic therapy of metastatic hormone-sensitive HER2-negative breast cancer
Dashyan G.A., Olchonova A.A., Dzhelyalov E.S., Akhmedov R.M., Sereda O.A., Vats A.B., Zhurov A.S., Shaikhelislamova L.F., Pushkaruk G.A., Belousov A.M.
New approaches to staging and treatment of primary endometrial cancer
Bakhidze E.V., Belyaeva A.V., Berlev I.V.
Neoadjuvant and postneoadjuvant treatment for triple negative breast cancer
Semiglazov V.F., Dzhelyalova M.A., Tseluyko A.I., Pesotsky R.S., Bessonov A.A., Semiglazova T.Y.
Rol' aflibertsepta v lechenii metastaticheskogo kolorektal'nogo raka
Meshcheryakov A.A.
LEChENIE TRIZhDY NEGATIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Dashyan G.A., Semiglazov V.V., Paltuev R.M., Migmanova N.S., Ivanova O.A., Tabagua T.T.
Structural and functional changes in the thyroid gland in the early and late periods after radiation therapy
Amergulov I.I., Pavlova M.G., Sych Y.P., Zhuravleva Y.R., Dolov M.M., Berdyklychev M.T., Dobrokhotova V.Z., Sannikova E.O., Trofimova O.P., Orlova M.V., Kuznetsova D.A., Bychkova N.M., Zaitseva N.A., Kandakova E.Y., Sotnikov V.M., Ryzhkova E.G., Fadeev V.V.
The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Semiglazov V.F., Krivorotko P.V., Bekkeldiyeva N.B., Komyakhov A.V., Emelyanov A.S., Gorina A.O.
EVEROLIMUS (AFINITOR): NOVYE VOZMOZhNOSTI TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Gorbunova V.A.
Rol' gistologicheskogo i molekulyarnogo analiza v vybore metoda lecheniya nemelkokletochnogo raka legkogo pozdnikh stadiy
Vladimirova L.Y., Kit O.I., Sholokhova E.A.
PRIMENENIE PREPARATA NEKSAVAR (SORAFENIB) DLYa LEChENIYa GEPATOTsELLYuLYaRNOGO RAKA
Bazin I.S.
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V.F., Krivorotko P.V., Komyakhov A.V., Semiglazova T.Y., Gigolaeva L.P., Tabagua T.T., Kazantseva M.D., Tergoeva A.P., Ulrikh D.G., Chervyak M.V., Klimenko V.V., Amirov N.S., Zhiltsova E.K., Semiglazov V.V.
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E.V., Frolova M.A., Menshikov S.F., Stenina M.B.
Non-small lung cancer. Expanding therapeutic opportunities: pembrolizumab in a number of malignant tumors
Gutorov S.L., Borisova E.I., Abramov M.E., Lud A.N., Arutyunyan E.A.
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
Borisova E.B., Gutorov S.L., Abramov M.E.
Novye vozmozhnosti ispol'zovaniya targetnoy terapii v lechenii nekotorykh solidnykh opukholey (po materialam ESMO-2014)
Dobrova N.V.
Assessing the risk of recurrence of luminal HER2-negative breast cancer and the possibility of intensifying adjuvant hormonal therapy to reduce the risk of progression
Gordeeva O.O.
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Pesotsky R.S., Semiglazov V.F., Krivorotko P.V., Tabagua T.T., Zernov K.Y., Emelyanov A.S., Semiglazova T.Y., Amirov N., Mortada V.V., Ulrikh D.G., Levchenko V.E., Rychagov K.Y., Zirov K.Y., Evseev V.N.
The effect of drug therapy and cetuximab on the mutational status of the KRAS gene in patients with squamous cell carcinoma of the tongue and oral floor mucosa
Lyanova A.A., Vladimirova L.Y., Kutilin D.S., Abramova N.A., Popova I.L., Tikhanovskaya N.M., Teplyakova M.A., Novoselova K.A., Myagkova V.S., Alieva F.V., Ryadinskaya L.A.
Efficacy of ramucirumab in the second-line treatment of patients with disseminated gastric cancer in routine clinical practice in Russia (RAMSELGA observational study)
Besova N.S., Titova T.A., Tryakin A.A., Artamonova E.V., Stroyakovsky D.L., Perminova E.V., Yukalchuk D.Y., Ponomarenko D.M., Belyak N.P., Orlova R.V., Teletaeva G.M., Ratner E.Y., Mochalova A.S., Zhabina A.S., Gamayunov S.V., Smolin A.V., Povyshev A.Y., Andrievskikh M.I., Stilidi I.S.
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience
Romashkina N.V., Klishina M.V., Karabina E.V.
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity
Gavrilova D.A., Besova N.S., Obarevich E.S., Makiev G.G., Tryakin A.A., Stilidi I.S.
Pelvic extrusion in patients with cervical cancer: clinical experience
Khakimov G.A., Khakimova G.G., Musurmonov K.U., Khakimova S.G., Orifjonova G.P.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y.I., Amergulov I.I., Likhodey N.V., Dzyuba A.S., Sych Y.P., Pavlova M.G.
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M.M., Kuzina L.I.
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E.V., Zhukova L.G., Gordeeva O.O., Drobot N.T., Kuznetsov A.V., Ganshina I.P.
Search for new prognostic and predictive markers of sensitivity to endocrine therapy, chemotherapy and immunotherapy of breast cancer
Semiglazov V.F., Pesotsky R.S., Tseluiko A.I., Dzhelyalova M.A., Apollonova V.S., Semiglazov V.V.
New possibilities of radionuclide therapy for patients with castration-resistant prostate cancer with bone metastases. The first experience of using radium-223 at the Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine
Vasilieva E.B., Tolpeykina K.A., Vazhenin A.V., Chvanova K.V.
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma
Zagoruyko V.A., Semiglazova T.Y., Radzhabova Z.A., Tkachenko E.V., Teletaeva G.M., Latipova D.K., Semenova A.I., Semiglazov V.V., Filatova L.V., Protsenko S.A.
New results of combination endocrinotherapy with ribocyclib
Kolyadina I.V.
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
Sakaeva D.D., Nasretdinov A.F.
Non-small cell lung cancer complicated by bleeding: a clinical case
Budurova M.D., Kanzapetov M.R., Davydov M.M., Gerasimov S.S., Khaylenko V.A.
ANALYSIS OF INFLUENCE ON THE BUDGET OF THE RUSSIAN FEDERATION OF THE USE OF ORAL VINORELBINE FOR THE TREATMENT OF METASTATIC BREAST CANCER
Shabalkin P.I.
EXPERIENCE OF USE OF NEOADJUVANT DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND CISPLATIN IN COMBINED TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER: PROSPECTIVE SINGLE-CENTER NON-RANDOMIZED CONTROLLED STUDY
Smirnova O.A., Bondarev N.E., Petrova A.S., Guseinov K.D., Mikaya N.A., Artemyeva A.S., Gorodnova T.V., Nekrasova E.A., Lavrynovych O.E., Bashlyk V.O., Nyuganen A.O., Abramova A.V., Sidoruk A.A., Ulrikh E.A., Semiglazova T.Y., Urmancheeva A.F., Berlev I.V.
New molecular subtypes of non-small cell lung cancer and the possibilities of their treatment
Moiseenko F.V., Kudryavtsev A.A., Myslik A.V., Volkov N.M.
Neoadyavant therapy of non-small cell lung cancer: are there any perspectives?
Ragulin Y.A.
Possibilities of metabiotic therapy in the correction of gastrointestinal symptoms and violations of intestinal microbiota in patients with lung cancer during chemotherapy
Serkova M.Y., Avalueva E.B., Orlov S.V.
WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?
Dobrova N.V., Borisova E.I., Gutorov S.L., Abramov M.E.
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
Semenova A.I., Protsenko S.A., Novik A.V., Latipova D.H., Teletayeva G.M., Semiglazova T.Y.
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Zhukova L.G., Ganshina I.P., Zaitsev V.G., Stepanchenko M.V.
Struktura slizistoy obolochki zheludka u bol'nykh rakom zheludka v Respublike Khakasiya
Tsukanov V.V., Kasparov E.V., Butorin N.N., Shtygasheva O.V., Vasyutin A.V., Amel'chugova O.S., Tonkikh Y.L., Bronnikova E.P.
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., Dashyan G.A., Paltuev R.M.
PERSPEKTIVY PRIMENENIYa S-1 V LEChENII BOL'NYKh RAKOM ZhELUDKA
Lud A.N., Abramov M.E., Meshcheryakov A.A.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.A.
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Semiglazova T.Y., Semiglazov V.V., Filatova L.V., Krivorot'ko P.V., Klimenko V.V., Ivanov V.G., Novikov S.M., Gershanovich M.L., Imyanitov E.N., Semiglazov V.F.
NASTOYaShchEE I BUDUShchEE TARGETNOY TERAPII V PERVOY LINII LEChENIYa RAKA YaIChNIKOV
Tyulyandina A.S.
Chemotherapy of head and neck squamous cell carcinoma (HNSCC)
Romanov I.S.
LOKOREGIONARNYE INTERVENTsIONNORADIOLOGIChESKIE TEKhNOLOGII V LEChENII GEPATOTsELLYuLYaRNOGO RAKA
Dolgushin B.I., Virshke E.R., Kosyrev V.Y., Martynkov D.V., Trofimov I.A., Breder V.V.
SEARCH FOR MARKERS OF EFFICIENCY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
Gutorov S.L., Borisova E.I., Chichikov E.I., Denisenko A.N., Borisova Y.I., Chichikov Y.I., Denisenko A.L., Gutorov S.L.
BONE METABOLISM AND EFFECTIVENESS OF ZOLEDRONIC ACID IN LOCALLY ADVANCED AND DISSEMINATED PROSTATE CANCER
Glybochko P.V., Alyaev Y.G., Vinarov A.Z., Demidko Y.L., Zelenova O.V., Shpot' E.V., Glybochko P., Alyaev Y.G., Vinarov A.Z., Demidko Y.L., Zelenova O.V., Shpot Y.V.
CONFERENCE OF RENAL CANCER EXPERTS: A REVIEW OF MATERIALS
Volkova M.I., Volkova M.I.
EFFECTIVENESS OF AFINITOR® (EVEROLIMUS) FOR METASTATIC KIDNEY CANCER
Borisov V.I., Borisov V.I.
NANOTEKhNOLOGII V DIAGNOSTIKE I LEChENII ZLOKAChESTVENNYKh OPUKhOLEY
Semiglazov V.F., Paltuev R.M., Semiglazov V.V., Dashyan G.A., Bessonov A.A., Pen'kov K.D., Vasil'ev A.G.
SUNITINIB (SUTENT) V PERVOY LINII LEChENIYa METASTATIChESKOGO RAKA POChKI
Gutorov S.L., Borisova E.I., Lichinitser M.R.
NEOAD\"YuVANTNAYa ENDOKRINOTERAPIYa RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Semiglazov V.V., Ivanov V.G.
Approaches to the diagnosis and treatment of patients with stage III–IV non-small cell lung cancer in Russia. Preliminary results of a retrospective multicenter non-interventional observational study
Reutova E.V., Laktionov K.K.
Trastuzumab deruxtecan in the treatment of breast cancer
Semiglazov V.F., Krivorotko P.V., Bekkeldieva N.B., Gorina A.O., Komyakhov A.V., Paltuev R.M., Tabagua T.T., Ereshenko S.S.
Reconstructive plastic surgery of the breast using autogenous tissue. Historical aspects
Khakimova S.G., Zikiryakhodzhaev A.D., Kaprin A.D., Khakimova G.G., Onofriychuk I.M., Rasskazova E.A., Sukhotko A.S., Vlasova M.Y., Bosieva A.R., Tokaev V.K.
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O.O., Meshcheryakova N.A., Meshcheryakov A.A.
Pathological regression as an indicator of the effectiveness of perioperative FLOT/FOLFOX in patients with resectable gastric cancer
Belyak N.P., Orlova R.V., Kutukova S.I., Pelipas Y.V., Androsova A.V., Zhukova N.V.
Clinical case of treatment of patient with HRD-positive ovarian cancer
Khokhlova S.V.
Effectiveness of a shortened cycle of monoimmunotherapy in non-small cell lung cancer
Artemieva E.V., Moiseenko F.V., Volkov N.M., Egorenkov V.V., Abduloeva N.K., Bogdanov A.A., Zhabina A.S., Levchenko N.V., Moiseenko V.M.
Potentials for the use of aflibercept in the treatment of patients with metastatic colorectal cancer
Vladimirova L.Y., Abramova N.A., Popova I.L., Storozhakova A.E., Novoselova K.A., Tikhanovskaya N.M., Ryadinskaya L.A., Lyanova A.A., Myagkova V.S., Teplyakova M.A., Kabanov S.N., Kalabanova E.A., Samaneva N.Y., Tishina A.V., Strakhova L.K., Yezhova M.O.
New possibilities for conservative management of patients with HPV-associated diseases of the cervix of the uterus
Bebneva T.N., Maltseva L.I.
Interim assesment of the results of a clinical study of the regularities of changes in the patterns of lipid peroxidation -antioxidant defence in stomach cancer
Smirnova O.V., Tsukanov V.V., Modestov A.A., Sinyakov A.A., Moskalenko O.L., Elmanova N.G., Ovcharenko E.S., Titova N.M.
Modern immunotherapy for kidney cancer
Protsenko S.A., Semenova А.I., Oganesyan A.P., Anokhina E.M., Novik A.V.
Efficacy and safety of therapy with biosimilar bevacizumab in the treatment of patients with metastatic colon cancer -a series of clinical observations
Fedyanin M.Y., Elsnukaeva K.K., Pokataev I.A., Sekhina O.V., Chekini D.A., Bulanov A.A., Tryakin A.A., Tyulyandin S.A.
EXPERIENCE OF PERSONALIZED APPOINTMENT OF NEOADJUVANT CHEMOTHERAPY FOR PATIENT WITH BREAST CANCER: A PROSPECTIVE STUDY
Slonimskaya E.M., Kazantseva P.V., Litviakov N.V., Tsyganov M.M., Ibragimova M.K., Doroshenko A.V., Vernadsky R.U., Vostrikova M.A., Lushnikova N.A.
BARRETT'S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: A NEW LOOK AT THE PROBLEM
Bakulin I.G., Belousova L.N.
Olaparib - promising direction in therapy in BRCA-associated tumors
Abramov M.E., Chichikov E.I., Borisova E.I., Gutorov S.L.
Long-term results of combined treatment of colorectal cancer patients with liver metastases
Chernoglazova E.V., Vyshinskaya G.V., Sagaidak I.V., Rotobelskaya L.E., Abramov M.E., Filonenko D.A.
PROSTATE-SPECIFIC ANTIGEN AS A CRITERION OF PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
Varlamov I.S., Varlamov S.A., Lazarev A.F.
APPLICATION OF REPLACEMENT THERAPY WITH PANCREATIN PREPARATIONS IN PATIENTS WITH PANCREATIC CANCER
Kucheryavy Y.A., Andreev D.N.
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Semiglazov V.F., Semiglazov V.V., Dashyan G.A., Krivorotko P.V., Nikolaev K.S., Semiglazova T.Y., Komyakhov A.V., Bessonov A.A., Donskikh R.V., Paltuev R.M., Zernov K.Y.
Prognoz bol'nykh kolorektal'nym rakom pri ozhirenii
Solodkiy V.A., Chkhikvadze V.D., Stanoevich U.S., Dekhissi E.I.
H. PYLORI-INFEKTsIYa: SOVREMENNYE REKOMENDATsII PO DIAGNOSTIKE I LEChENIYu
Gratsianskaya A.N.
LAPATINIB PRI RAKE MOLOChNOY ZhELEZY
Fray I.V., Perevodchikova N.I.
METODOLOGIChESKIE ASPEKTY MORFOLOGIChESKOY DIAGNOSTIKI I OTsENKI LEChEBNOGO PATOMORFOZA TROYNOGO NEGATIVNOGO RAKA MOLOChNOY ZhELEZY
Andreeva Y.Y., Zavalishina L.E., Danilova N.V., Ilatovskaya M.E., Frank G.A.
ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Semiglazov V.F., Dashyan G.A., Semiglazova T.Y., Paltuev R.M., Zernov K.Y., Pen'kov K.D., Grechukhina I.A., Semiglazov V.V.
Hormonal treatment of breast cancer: optimal sequence and issues of overcoming the resistance
Borisova E.I., Gutorov S.L., Vorontsov A.Y.
Current potentials for the drug therapy of adrenocortical cancer
Filimonyuk A.V.
1 - 100 of 317 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"